Dr. Russell Chiappetta, MD Orthopaedic Surgery Medicare: Medicare Enrolled Practice Location: 360 N Main St, Southington, CT 06489 Phone: 860-628-4719 Fax: 860-620-0188 |
News Archive
In an effort to hasten the research on identifying antiviral drugs for SARS-CoV-2 infection, researchers from the U.S. and Switzerland performed extensive drug screening for antiviral activity using live virus infection in human respiratory cells. As a result, they identified a set of possible drug candidates that could potentially be tested in clinical trials.
The National Sleep Foundation is pleased to announce the launch of a comprehensive free online sleep disorders resource for all professionals in primary care. The "Sleep Disorders" guide is the updated web version of Dr. Peter Hauri's book, The Sleep Disorders, first published in 1977.
The bacterium that causes tuberculosis has a unique molecule on its outer cell surface that blocks a key part of the body's defense. New research suggests this represents a novel mechanism in the microbe's evolving efforts to remain hidden from the human immune system.
Today Phadia announced that it has received FDA 510 (K) clearance for four new EliA autoimmune antibody assays. These new assays will provide physicians with additional tools needed to aid in the diagnosis of Antiphospholipid Syndrome. The newly available EliA assays, anti-cardiolipin (aCL) IgG/IgM and anti-B2-glycoprotein 1 (anti-B2-GP1) IgG/IgM, have proven to be essential, sensitive, and specific markers to aid in the diagnosis of APS.
A new review of four randomized controlled trials that directly compared two different treatments for small inoperable liver tumors has found that radiofrequency ablation (RFA) significantly improves patient survival compared to the standard therapy of percutaneous ethanol injection (PEI).
› Verified 6 days ago